Cite
HARVARD Citation
Avivi, I. et al. (2022). BNT162b2 mRNA COVID‐19 vaccine booster induces seroconversion in patients with B‐cell non‐Hodgkin lymphoma who failed to respond to two prior vaccine doses. British journal of haematology. pp. 1329-1333. [Online].